CU Doctors are here for you!
Our clinics are open and able to serve you during this time for urgent in-person visits as well as virtual health services. Please call our clinics directly to schedule an appointment for both in person and virtual health.
Our number one priority is the health and safety of our patients, their family members, as well as our health care team. To honor this commitment we have implemented the following procedures:
- Non-urgent medical appointments should be converted to telehealth visits or rescheduled if telehealth is not feasible.
- Please bring your own face mask or covering to wear. Patients checking in must tell staff if they have: A fever, cold symptoms (cough, sore throat, runny nose, shortness of breath); Flu symptoms (fever, chills, body aches, etc.).
- Adult patients may be allowed one asymptomatic person (at least 17 years old) for support; however, we reserve the right to deem a support person unnecessary at any time.
- Pediatric patients may be allowed one asymptomatic adult (i.e. parent, guardian) for support.
- For pediatric patients, please check the Children's Hospital Colorado website for updated COVID-19 related patient information.
Please call us about your current health care concerns. Please take care in following current public health guidelines. Please visit the Colorado COVID-19 website, for more information.
Thank you for doing your part to help keep everyone safe and healthy!
Dan Sherbenou, MD, PhD
Assistant Professor, Medicine-Hematology
UCH - Cancer Center
1665 Aurora Ct
More providers at this location
University of Colorado Hospital
Conditions & Treatments
Internal Medicine - Hematology, Board Certification
Internal Medicine, Board Certification
Internal Medicine - Medical Oncology
Colorado Medical License , License
Blood and Marrow Transplant
Leukemia (Adult Acute)
Leukemia (Adult Chronic)
Clinical Interest for Patients
Multiple myeloma and related plasma cell disorders
I have devoted my professional life to understanding what makes cells become cancerous and how to turn that knowledge into the best possible treatments. I seek to empower my patients with knowledge about their disease and its treatments. For me, it is a privilege to provide cancer care and I strive to help patients realize their best possible quality of life.
As an undergraduate at the University of Colorado, I started my scientific career focused on basic science research of cancer. In the laboratory of Dr. Min Han, I studied the Ras cell signaling pathway using the C. elegans model organism. In the MD/PhD program at Oregon Health & Science University, I focused on translational leukemia research. Under the mentorship of Drs. Brian Druker and Michael Deininger, I studied chronic myeloid leukemia. My thesis evaluated mechanisms of kinase inhibitor resistance in patients treated with imatinib (Gleevec).
In oncology fellowship at University of California at San Francisco, I focused on the study of antibody-based therapeutics under the mentorship of Dr. Bin Liu. Antibody-drug conjugates (ADCs) are another rapidly growing approach to cancer treatment. With Dr. Liu, I conducted preclinical analyses of a novel ADC for multiple myeloma, with hope for this to soon lead to transition to the clinic.
Now a faculty member at UC Denver in the Hematology division, I oversee a translational research laboratory focused on novel therapy development and optimization for multiple myeloma and care for patients with myeloma and related plasma cell disorders from Colorado and adjoining areas.
In my spare time, I enjoy spending time with my wife and 2 young sons. I love the mountains and spending time outdoors, hiking, road biking, mountain biking and rock climbing.